Sign in Subscribe
Coronaviruses

US Aims to Launch Covid Vaccination Program in Early December

Strategic Insights

— 1 min read

The United States is gearing up to roll out its Covid-19 vaccination program, with the head of the government's coronavirus vaccine effort, Moncef Slaoui, stating that the plan is to ship vaccines to immunization sites within 24 hours of FDA approval. This comes as Pfizer and Moderna's vaccine candidates have shown to be at least 95% effective, with Pfizer already applying for emergency use authorization from the FDA. The US is aiming to vaccinate 20 million people in December, with 30 million per month thereafter.

Key Takeaways:

  • The US plans to ship Covid-19 vaccines to immunization sites within 24 hours of FDA approval, with the FDA vaccine advisors meeting on December 8 to 10 to discuss approval.
  • Pfizer and Moderna's vaccine candidates have shown to be at least 95% effective in preventing Covid-19, with Pfizer already applying for emergency use authorization from the FDA.
  • The US aims to vaccinate 20 million people in December, with 30 million per month thereafter.
  • The FDA has approved an emergency use authorization for Pfizer's Covid-19 vaccine, pending the outcome of the advisory committee meeting on December 10.
  • The US had 177,552 new Covid-19 infections on Saturday, with an average of almost 110,000 more daily cases than a month ago.
  • The US FDA has approved an antibody cocktail from Regeneron Pharmaceuticals Inc. for coronavirus treatment.
  • G20 nations are pushing for global "equitable" access to vaccines, with concerns that poorer nations will be left behind.

Statistics:

  • 20 million: The number of people the US aims to vaccinate in December.
  • 30 million: The number of people the US aims to vaccinate per month after December.
  • 95%: The efficacy rate of Pfizer and Moderna's Covid-19 vaccine candidates.
  • 177,552: The number of new Covid-19 infections reported in the US on Saturday.
  • 110,000: The average increase in daily Covid-19 cases in the US compared to a month ago.

Sources:

  • CNN: Moncef Slaoui, the head of the government's coronavirus vaccine effort, in a statement to CNN on Sunday.
  • US FDA: Pfizer's application for emergency use authorization for its Covid-19 vaccine.
  • Pfizer: Application posted on the company's website on Friday.
  • FDA: Meeting of the advisory committee scheduled for December 10.
  • Regeneron Pharmaceuticals Inc.: Approval of their antibody cocktail for coronavirus treatment.

Read more